nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
|
Monda, Vincenzo M. |
|
|
11 |
9 |
p. 1909-1914 |
artikel |
2 |
Are SGLT-2 Inhibitors the Future of Heart Failure Treatment? The EMPEROR-Preserved and EMPEROR-Reduced Trials
|
Williams, David M. |
|
|
11 |
9 |
p. 1925-1934 |
artikel |
3 |
A Review on Semaglutide: An Oral Glucagon-Like Peptide 1 Receptor Agonist in Management of Type 2 Diabetes Mellitus
|
Kalra, Sanjay |
|
|
11 |
9 |
p. 1965-1982 |
artikel |
4 |
Basal-Bolus Insulin Regimen for Hospitalised Patients with COVID-19 and Diabetes Mellitus: A Practical Approach
|
Attri, Bhawna |
|
|
11 |
9 |
p. 2177-2194 |
artikel |
5 |
Burden of Diabetes and Prediabetes in Nepal: A Systematic Review and Meta-Analysis
|
Shrestha, Nipun |
|
|
11 |
9 |
p. 1935-1946 |
artikel |
6 |
Clinical Efficacy of Quadruple Oral Therapy for Type 2 Diabetes in Real-World Practice: A Retrospective Observational Study
|
Cho, Yun Kyung |
|
|
11 |
9 |
p. 2029-2039 |
artikel |
7 |
Diabetes and Novel Coronavirus Infection: Implications for Treatment
|
Williams, David M. |
|
|
11 |
9 |
p. 1915-1924 |
artikel |
8 |
Does Renal Function or Heart Failure Diagnosis Affect Primary Care Prescribing for Sodium-Glucose Co-Transporter 2 Inhibitors in Type 2 Diabetes?
|
Hinton, William |
|
|
11 |
9 |
p. 2169-2175 |
artikel |
9 |
Effect of Sodium-Glucose Cotransporter-2 Inhibitors on Endothelial Function: A Systematic Review of Preclinical Studies
|
Alshnbari, Afnan S. |
|
|
11 |
9 |
p. 1947-1963 |
artikel |
10 |
Establishment of a Risk Prediction Model for Non-alcoholic Fatty Liver Disease in Type 2 Diabetes
|
Zhang, Yali |
|
|
11 |
9 |
p. 2057-2073 |
artikel |
11 |
Insights into the Role of Renal Biopsy in Patients with T2DM: A Literature Review of Global Renal Biopsy Results
|
Tong, Xue |
|
|
11 |
9 |
p. 1983-1999 |
artikel |
12 |
Insulin-Induced Skin Lipohypertrophy in Type 2 Diabetes: a Multicenter Regional Survey in Southern Italy
|
Gentile, Sandro |
|
|
11 |
9 |
p. 2001-2017 |
artikel |
13 |
Long-Term Cost-Effectiveness Analyses of Empagliflozin Versus Oral Semaglutide, in Addition to Metformin, for the Treatment of Type 2 Diabetes in the UK
|
Ramos, Mafalda |
|
|
11 |
9 |
p. 2041-2055 |
artikel |
14 |
Prescription of Sulphonylureas among Patients with Type 2 Diabetes Mellitus in Italy: Results from the Retrospective, Observational Multicentre Cross-Sectional SUSCIPE (Sulphonyl_UreaS_Correct_Internal_Prescription_Evaluation) Study
|
Giorda, Carlo Bruno |
|
|
11 |
9 |
p. 2105-2119 |
artikel |
15 |
Relationship Between Estimated Glycosylated Hemoglobin Using Flash Glucose Monitoring and Actual Measured Glycosylated Hemoglobin in a Chinese Population
|
Hu, Yun |
|
|
11 |
9 |
p. 2019-2027 |
artikel |
16 |
Role of FTO and MC4R Polymorphisms in Escalating Obesity and Their Indirect Association With Risk of T2D in Indian Population
|
Khan, Shahbaz |
|
|
11 |
9 |
p. 2145-2157 |
artikel |
17 |
Subpopulation Differences in the Cardiovascular Efficacy of Long-Acting Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
|
He, Liyun |
|
|
11 |
9 |
p. 2121-2143 |
artikel |
18 |
Switching to Degludec is Associated with Reduced Hypoglycaemia, Irrespective of Definition Used or Patient Characteristics: Secondary Analysis of the ReFLeCT Prospective, Observational Study
|
de Valk, Harold W. |
|
|
11 |
9 |
p. 2159-2167 |
artikel |
19 |
Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients With Type 2 Diabetes: PRONTO-T2D Subpopulation Analysis
|
Jinnouchi, Hideaki |
|
|
11 |
9 |
p. 2075-2088 |
artikel |
20 |
Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients with Type 1 Diabetes: PRONTO-T1D Subpopulation Analysis
|
Miura, Junnosuke |
|
|
11 |
9 |
p. 2089-2104 |
artikel |